RADIOMEDIX Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for RADIOMEDIX with the United States Patent and Trademark Office. The USPTO has given the RADIOMEDIX trademark a serial number of 98384574. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, November 22, 2024. This trademark is owned by RadioMedix, Inc.. The RADIOMEDIX trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing of pharmaceuticals

Pharmaceuticals for the treatment of cancer; drugs targeted for radiotherapy, namely, pharmaceutical products for the treatment of cancer; drugs labeled with isotopes for selective delivery of radioactive payload to cancer cells, namely, pharmaceutical products for the treatment of cancer; radioisotopes, namely, radio-isotope markers for therapeutic or diagnostic use; reagents for use in diagnostic tests for medical purposes;

Medical research services; pre-clinical studies, namely, scientific research, clinical studies of radiolabeled drugs, namely, scientigic research in the nature of conducting clinical trials for others

General Information


Serial Number98384574
Word MarkRADIOMEDIX
Filing DateWednesday, January 31, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, November 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacturing of pharmaceuticals
Goods and ServicesPharmaceuticals for the treatment of cancer; drugs targeted for radiotherapy, namely, pharmaceutical products for the treatment of cancer; drugs labeled with isotopes for selective delivery of radioactive payload to cancer cells, namely, pharmaceutical products for the treatment of cancer; radioisotopes, namely, radio-isotope markers for therapeutic or diagnostic use; reagents for use in diagnostic tests for medical purposes;
Pseudo MarkRADIO MEDIC
Goods and ServicesMedical research services; pre-clinical studies, namely, scientific research, clinical studies of radiolabeled drugs, namely, scientigic research in the nature of conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 31, 2024
Primary Code005
First Use Anywhere DateTuesday, January 24, 2006
First Use In Commerce DateTuesday, January 24, 2006

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, November 22, 2024
Primary Code040
First Use Anywhere DateTuesday, January 24, 2006
First Use In Commerce DateTuesday, January 24, 2006

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code042
First Use Anywhere DateTuesday, January 24, 2006
First Use In Commerce DateTuesday, January 24, 2006

Trademark Owner History


Party NameRadioMedix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77042

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024NEW APPLICATION ENTERED
Friday, May 31, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2024NON-FINAL ACTION E-MAILED
Monday, August 26, 2024NON-FINAL ACTION WRITTEN
Monday, August 26, 2024ASSIGNED TO EXAMINER
Monday, August 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED